Cat. No. 1117
Chemical Name: N-(Piperidin-1-yl)-5-(4-iodophenyl)
Biological ActivityPotent CB1 receptor antagonist (IC50 = 8 nM, Ki = 7.49 nM) that displays 306-fold selectivity over CB2 receptors. Also potent GPR55 agonist (EC50 = 39 nM). Also available as part of the Cannabinoid CB1 Receptor Tocriset™; and in a fluorescent form (Cat. No. 2540).
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Certificate of Analysis / Safety Data Sheet
Gatley et al (1996) 125I-labeled AM 251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur.J.Pharmacol. 307 331. PMID: 8836622.
Gatley et al (1997) Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors. Life Sci. 61 191. PMID: 9335234.
Lan et al (1999) Structure-activity relationships of pyrazole derivatives as cannabinoid receptor antagonists. J.Med.Chem. 42 769. PMID: 10052983.
Pertwee (2005) Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. Life Sci. 76 1307. PMID: 15670612.
Ryberg et al (2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br.J.Pharmacol. 152 1092. PMID: 17876302.
If you know of a relevant citation for this product please let us know.
Keywords: AM 251, supplier, Potent, CB1, antagonist, GPR55, agonist, cannabinoid, receptors, AM251, cb1r
Find multiple products by catalog number
New Products in this Area
TFA salt of virodhamine, an endogenous cannabinoid receptor mixed agonist/antagonist
One Day Symposium
March 17, 2015